Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1372839)

  • 1. Constitutional translocation (8;13) in a patient with non-Hodgkin's lymphoma.
    Salles MT; Neyra O; Taja L; Cervantes G; Gagnière M; Cerrillo M; Mohar A; Osornio A; Reynoso E; Gorodezky G
    Cancer Genet Cytogenet; 1992 Mar; 59(1):80-3. PubMed ID: 1372839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
    Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lactic acidosis in non-Hodgkin's lymphoma].
    Navigante AH; Chacón RD
    Medicina (B Aires); 1985; 45(6):667-9. PubMed ID: 2431249
    [No Abstract]   [Full Text] [Related]  

  • 4. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Longo DL; DeVita VT; Young RC
    N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
    [No Abstract]   [Full Text] [Related]  

  • 5. Hybrid cytogenetics of chronic lymphocytic leukemia and follicular cell lymphoma in a case of non-Hodgkin's lymphoma.
    Babu Rao V; Kerketta L; Madkaikar M; Farah J; Ghosh K
    Acta Haematol; 2006; 116(2):150-2. PubMed ID: 16914914
    [No Abstract]   [Full Text] [Related]  

  • 6. VACOP-B chemotherapy for high grade non-Hodgkin's lymphoma in pregnancy.
    Rodriguez JM; Haggag M
    Clin Oncol (R Coll Radiol); 1995; 7(5):319-20. PubMed ID: 8580059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
    Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.
    Miller TP; Dahlberg S; Weick JK; Files JC; Eyre HJ; Pendergrass KB; Fisher RI
    J Clin Oncol; 1990 Dec; 8(12):1951-8. PubMed ID: 1700079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
    Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
    J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modified CHOP-Bleo protocol in the treatment of malignant non-Hodgkin's lymphoma of low cell differentiation].
    Płuzańska A; Małecka E; Krykowski E; Olszańska-Skorek T; Stempczyńska J; Polkowska E; Hyjek E
    Pol Arch Med Wewn; 1988 Dec; 80(6):323-30. PubMed ID: 2481844
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.
    Meerwaldt JH; Carde P; Somers R; Thomas J; Kluin-Nelemans JC; Bron D; Noordijk EM; Cosset JM; Bijnens L; Teodorovic I; Hagenbeek A
    Ann Oncol; 1997; 8 Suppl 1():67-70. PubMed ID: 9187434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chylothorax resulting from malignant non Hodgkin's lymphoma].
    Ohyama S; Bando K; Hasegawa Y; Taniguti M; Shirayma H
    Nihon Kokyuki Gakkai Zasshi; 1998 May; 36(5):473-7. PubMed ID: 9742867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
    Hehn ST; Miller TP
    Curr Hematol Rep; 2004 Jan; 3(1):17-26. PubMed ID: 14695845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
    Inhorn RC; Aster JC; Roach SA; Slapak CA; Soiffer R; Tantravahi R; Stone RM
    Blood; 1995 Apr; 85(7):1881-7. PubMed ID: 7661940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Sweetenham JW; Mead GM; Whitehouse JM
    J Clin Oncol; 1991 Dec; 9(12):2202-9. PubMed ID: 1720454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
    Konopka L; Pawelski S
    J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
    Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous occurrence of der(1;7)(q10;p10) and t(14;18)(q32;q21) in non-Hodgkin's lymphoma: der(1;7) will appear as a secondary change in lymphoid neoplasia.
    Hsiao HH; Sashida G; Ito Y; Tachino M; Beppu H; Ohyashiki K
    Leuk Lymphoma; 2005 Jun; 46(6):949-50. PubMed ID: 16019545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.